Illumina (ILMN) | Stock Overview & Key Data
Illumina Performance Comparison
Stock Range
Today's Range
Low: $99.08
High: $101.55
on August 21, 2025
52 Week Range
Low: $68.70
High: $156.66
on April 9, 2025
on November 5, 2024
All-Time High: $540.63 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$15.8B
EPS
7.90
P/E Ratio (TTM)
12.67
Forward P/E
22.65
P/B Ratio
6.83
PEG Ratio
-0.11
Div. Yield
N/A
ROE
68.06%
Beta
1.372
Debt to Equity
115.06
Financial Highlights
Profitability
Gross Margin
65.63%
Operating Margin
18.79%
Profit Margin
29.34%
Returns and Earnings
Return on Assets (TTM)
4.25%
Return on Equity (TTM)
68.06%
EBITDA
$1.3B
Net Income (TTM)
$1.3B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$26.94
Quarterly Revenue Growth (YoY)
-4.80%
Quarterly Earnings Growth (YoY)
-4.77%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Illumina ILMN | 15.85B Large-cap | -0.80% | 4.74% | 25.10% | 5.40% | -24.17% | -24.43% | -50.30% | -71.17% |
| Thermo Fisher TMO | 184.10B Large-cap | -0.26% | 19.46% | 21.46% | -9.16% | -7.43% | -20.19% | -14.18% | 13.97% |
| Danaher DHR | 151.04B Large-cap | -3.01% | 8.42% | 9.15% | -3.01% | -11.27% | -24.34% | -17.95% | 11.85% |
| Idexx Laboratories IDXX | 50.94B Large-cap | -3.20% | 21.54% | 26.39% | 39.82% | 54.84% | 29.69% | 80.92% | 64.87% |
| Agilent Technologies A | 33.94B Large-cap | -1.45% | 4.56% | 7.57% | -13.46% | -12.20% | -16.84% | -9.79% | 17.27% |
| Iqvia Holdings IQV | 32.73B Large-cap | -2.12% | 16.63% | 35.04% | -2.96% | -4.99% | -25.53% | -15.61% | 14.99% |
Ownership & Short Interest
Insider Ownership
0.19%
Institutional Ownership
102.93%
Shares Short
8M
Short Ratio
3.43
Short % of Shares Outstanding
7.48%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Illumina Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Illumina would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ILMN's 52-week high and low?
- In the last 52 weeks, Illumina reached a high of $156.66 (on November 5, 2024) and a low of $68.70 (on April 9, 2025).
- What is the market cap and P/E ratio for ILMN?
- Curious about Illumina's size and valuation? Its market capitalization stands at 15.85B. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.67, and the forward P/E (looking ahead) is 22.65.
- Does ILMN pay dividends? If so, what's the yield?
- As for dividends, Illumina isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Illumina's main competitors or similar companies to consider before investing?
When looking at Illumina, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.10B Healthcare Diagnostics & Research -20.19% -14.18% Danaher
DHR151.04B Healthcare Diagnostics & Research -24.34% -17.95% Idexx Laboratories
IDXX50.94B Healthcare Diagnostics & Research 29.69% 80.92% Agilent Technologies
A33.94B Healthcare Diagnostics & Research -16.84% -9.79% Iqvia Holdings
IQV32.73B Healthcare Diagnostics & Research -25.53% -15.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Illumina, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Illumina's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 68.06%, the Debt to Equity ratio from the most recent quarter is 115.06, and its Gross Profit Margin stands at 65.63%.
- What is the recent revenue and earnings growth for ILMN?
- Looking at Illumina's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by -4.80%, and quarterly earnings saw a YoY growth of -4.77%.
- How much of ILMN stock is held by insiders and institutions?
- Wondering who owns Illumina stock? Company insiders (like executives and directors) hold about 0.19% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 102.93%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.